• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Reducing COVID-19 vaccine hesitancy

Article

Vaccine hesitancy is nothing new in pediatrics. However, the increased hesitancy for the COVID-19 vaccine could prove problematic.

As anyone in pediatrics knows, vaccine hesitancy is a source of frustration with a seemingly increasing number of families saying no to vaccines with decades of proven efficacy and safety records. The 2019 measles epidemic in the United States offered a potential look at what could happen as hesitancy continued to proliferate.

Then, the pandemic started with many people’s hope centered on a vaccine. The emergency use authorization of the Pfizer/BioNTech and Moderna vaccines has started to stem the tide of the pandemic, which has become even more important with the rise of variants. However, the growing vaccine hesitancy along with the fact that the coronavirus 2019 vaccine became politicized have created a potential public health issue.

To tackle these concerns, our sister publication Medical Economics spoke with Paul Hain, MD, about how to have effective conversations to tackle this hesitancy.

Related Videos
Importance of maternal influenza vaccination recommendations
Samantha Olson, MPH
Related Content
© 2024 MJH Life Sciences

All rights reserved.